SCHEMBL8447233

SCHEMBL8447233

CN(C)c1ccc(CSCCCC[C@H](NC(=O)C(C)(C)CS)C(=O)O)cc1

nearest known ligand 0.53

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ACE P12821 15/20 0.53
FOLH1 Q04609 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8454004 0.93 ACE (0.56) ACEFOLH1
SCHEMBL8447630 0.87 ACE (0.69) ACE
SCHEMBL8453551 0.84 ACE (0.43) ACEFOLH1
SCHEMBL6574034 0.82 PPARA (0.56) ACE
SCHEMBL8446649 0.82 ACE (0.41) ACEFOLH1
SCHEMBL6574069 0.79 ACE (0.57) ACE
SCHEMBL8447649 0.79 ACE (0.57) ACE
SCHEMBL8449770 0.78 ACE (0.43) ACEFOLH1
SCHEMBL6578261 0.78 ACE (0.57) ACE
SCHEMBL8450604 0.78 ACE (0.57) ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5872281-A COMPOUNDS FOR TREATMENT OF RHEUMATIC DISEASES, PSORIASIS, INTESTINAL INFLAMATION SANTEN PHARMACEUTICAL CO., LTD. (JP) 1999-02-16 US disclosed